Literature DB >> 7216486

Factors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid.

B J Wilkinson, Y Kim, P K Peterson.   

Abstract

In a previous study, Staphylococcus aureus purified cell walls (PCW), consisting of peptidoglycan (PG) plus covalently linked teichoic acid (TA), were found to be more active in complement consumption than isolated PG. Isolated TA has now been shown to be capable of activating complement. Mild sonication markedly increased the ability of PG to activate complement but had essentially no effect on the activities of PCW and TA. Optimal sonication of PG did not yield activities equal to those of PCW in dose-response and kinetic studies, which may imply that TA plays some role in complement consumption. Sonication did not lead to solubilization of PCW or PG but may have enhanced the activity of PG in complement consumption by better dispersing PG particles, thereby exposing more surface area. Lysostaphin solubilization of PCW and PG markedly decreased their activities in complement consumption. The PCW of an S. aureus TA-deficient mutant, which were mostly PG, caused similar amounts of complement consumption as the parent strain PCW. Of the treatments of PCW commonly used to isolate PG, formamide and periodate extractions in particular led to PG preparations with lower activities in complement consumption than the PCW from which they were prepared, although these activities were stimulated by sonication. When whole organisms were studied by using a TA-deficient mutant, a mutant with an additional cell surface polymer, and the TA-containing parent strains and complement consumption by these strains was compared, no difference was found in either the rate or the degree of complement activation. This led to experiments demonstrating that both material released extracellularly from staphylococci and the cytoplasmic fraction of S. aureus were active in complement consumption. The results of these experiments indicate that both physical and chemical factors must be considered in studies of complement activation by isolated bacterial cell wall components. Under certain conditions, staphylococcal TA may enhance complement activation, but studies with whole organisms clearly show that this cell wall constituent does not play an essential role in this process. In addition, studies of complement consumption with intact organisms have demonstrated that there may be contributions both from cell surface components and from material released by the cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216486      PMCID: PMC350610          DOI: 10.1128/iai.32.1.216-224.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1976-06-01

Review 2.  Peptidoglycan types of bacterial cell walls and their taxonomic implications.

Authors:  K H Schleifer; O Kandler
Journal:  Bacteriol Rev       Date:  1972-12

3.  Mutants of staphylococci with altered cell walls.

Authors:  J T Park; D R Shaw; A N Chatterjee; D Mirelman; T Wu
Journal:  Ann N Y Acad Sci       Date:  1974-07-31       Impact factor: 5.691

4.  Ribitol teichoic acid synthesis in bacteriophage-resistant mutants of Staphylococcus aureus H.

Authors:  D R Shaw; D Mirelman; A N Chatterjee; J T Park
Journal:  J Biol Chem       Date:  1970-10-10       Impact factor: 5.157

5.  The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.

Authors:  V Brade; G D Lee; A Nicholson; H S Shin; M M Mayer
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

6.  Dual pathways of complement interaction with guinea pig immunoglobulins.

Authors:  A L Sandberg; A G Osler
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

7.  Teichoic acids and membrane function in bacteria.

Authors:  S Heptinstall; A R Archibald; J Baddiley
Journal:  Nature       Date:  1970-02-07       Impact factor: 49.962

8.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

9.  Studies on the linkage between teichoic acid and peptidoglycan in a bacteriophage-resistant mutant of Staphylococcus aureus H.

Authors:  J E Heckels; A R Archibald; J Baddiley
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

10.  Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.

Authors:  J W Tauber; M J Polley; J B Zabriskie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  13 in total

1.  Induction of meningeal inflammation by diverse bacterial cell walls.

Authors:  E Tuomanen; B Hengstler; O Zak; A Tomasz
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

2.  Arthropathic properties of gonococcal peptidoglycan fragments: implications for the pathogenesis of disseminated gonococcal disease.

Authors:  T J Fleming; D E Wallsmith; R S Rosenthal
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

3.  Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.

Authors:  Andrew Watts; Danbing Ke; Qun Wang; Anil Pillay; Anne Nicholson-Weller; Jean C Lee
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Morphological examination of the glycocalyces of Staphylococcus aureus strains Wiley and Smith.

Authors:  G G Caputy; J W Costerton
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  Complement consumption gonococcal peptidoglycan.

Authors:  B H Petersen; R S Rosenthal
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus.

Authors:  K J Mayberry-Carson; B Tober-Meyer; J K Smith; D W Lambe; J W Costerton
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Detection of muramic acid in a carbohydrate fraction of human spleen.

Authors:  M A Hoijer; M J Melief; C G van Helden-Meeuwsen; F Eulderink; M P Hazenberg
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Interaction of purified lipoteichoic acid with the classical complement pathway.

Authors:  M Loos; F Clas; W Fischer
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Resistance of O-acetylated gonococcal peptidoglycan to human peptidoglycan-degrading enzymes.

Authors:  R S Rosenthal; W J Folkening; D R Miller; S C Swim
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes.

Authors:  M W Qoronfleh; B J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.